Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease. - Wikidata - awgldk - TriplyDB

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

http://www.wikidata.org/entity/Q36626757

about

The prion hypothesis in Parkinson's disease: Braak to the future Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications The neurobiological basis of cognitive impairment in Parkinson's disease.Exploring Braak's Hypothesis of Parkinson's Disease.Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease Parkinson disease and incidental Lewy body disease: Just a question of time?The Synucleinopathies: Twenty Years On.Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies.Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Synaptic failure and α-synuclein.Neuropathological basis of nonmotor manifestations of Parkinson's disease.Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective.Selective neuronal vulnerability in Parkinson disease.In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.Quantifying rigidity of Parkinson's disease in relation to laxative treatment: a service evaluation.Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.Pattern of Reduced Functional Connectivity and Structural Abnormalities in Parkinson's Disease: An Exploratory Study Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Parkinson's Disease Is Not Simply a Prion Disorder.Prying into the Prion Hypothesis for Parkinson's Disease.Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson's disease.Role of α-synuclein in neurodegeneration: implications for the pathogenesis of Parkinson's disease.Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders.On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.

P2860

Q22001062-C807652F-1991-428D-AFAB-A777D5482B20 Q26801733-88C975F5-5C8C-4CFC-BCAE-B5DB79B6212D Q27686808-EB463B9A-FCDA-418A-9108-546AFD2EE6F4 Q27686837-F48EEB4F-56CE-4F4C-9E37-7C5931676B4C Q28298135-8F3049F2-C1D6-4B6B-9D62-311ECE19DCD9 Q33724698-B141C723-639E-45A4-B975-311D26100FE1 Q34552244-26BE661E-FBC1-4EB7-85E5-7104E23F0E93 Q35667600-2E8C77C8-A8A2-46B1-911B-6A53C97A572E Q35897340-9328AEEA-277A-4A14-A6D3-E8AD9334AC8B Q36300086-4C79DCD2-4FD8-425C-9388-750237CD52E6 Q37693375-6C70F407-BA26-46C1-B01D-CCB92D088241 Q38079791-74FF905A-7268-449F-9E03-CE4D968FC4D3 Q38435692-68D347E0-0543-4575-ACE1-EBF5FCCFEF46 Q38541943-4B06640E-A9CB-4168-ABA4-9EA81B75D493 Q38603309-0DE1BDE0-BA26-4DA1-8157-209FFE881AC1 Q38636630-ABF562B9-BDEA-4C0F-AAE4-2E869DBB1385 Q38667942-9BFB5AC6-C602-4911-A281-306F5372A300 Q38704236-2BF8735A-86BF-4B71-A6FD-690BF03F4824 Q38794098-9CE68D80-1AAB-4211-B5AB-19B9C351BECC Q38947507-B827B478-8B4A-4EFD-9FCC-8AE02C55EADF Q39095738-561E81AA-29E2-4569-BB72-03C88C9AA4BA Q39758264-F70F779C-C704-419C-9721-AEA859535EFB Q39967268-E36D784D-7A11-47EA-A009-69496FAD9DB4 Q40721262-B92349F9-332A-43E0-8778-DAC504604527 Q41589030-BA1DF3AD-CFB9-47A7-AFE7-FBF892B727CB Q41681113-45887C08-F198-48E6-8009-76850432CFF5 Q42054485-9F43E827-DBD4-437B-8FCA-6622C5B019BD Q42462932-C4C65695-9C10-41B0-8B4F-40C7280163D4 Q46308077-50BFE3EC-44BE-4F9D-A6BA-6258893C067D Q46354756-1A56DA01-43B1-43C2-B83C-4B9A1ABB7ACF Q47314960-1C119D0F-52F9-490F-B83E-6CE611C18002 Q47665674-333866B2-CC23-4B18-99FC-465F4167F612 Q48091832-7C19B2E3-A951-4C8A-B801-9F3E6F8551E4 Q48599325-C3E29D19-B351-4682-B7D4-81B73591D0CE Q48676257-8D359EE5-B665-4486-9711-757B6C2DBC29 Q55305758-5A7BDCEE-F414-49D7-BF39-D789E3547171 Q55432445-0FD7B687-7DC5-4AD6-9055-89F703E0F7E7

P2860

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

http://www.wikidata.org/entity/Q36626757

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Lewy pathology is not the firs ...... neurons in Parkinson disease.

@ast

Lewy pathology is not the firs ...... neurons in Parkinson disease.

@en

type

label

Lewy pathology is not the firs ...... neurons in Parkinson disease.

@ast

Lewy pathology is not the firs ...... neurons in Parkinson disease.

@en

prefLabel

Lewy pathology is not the firs ...... neurons in Parkinson disease.

@ast

Lewy pathology is not the firs ...... neurons in Parkinson disease.

@en

P1433

Q36626757-1C10C01E-17EB-4B12-B84E-83A8AFCE1B7F

P1476

Q36626757-68E897EC-4A95-4200-BC7A-109D46D668CE

P2093

Q36626757-33DE833D-77D2-43B4-A66B-DC1541C29E1E

Q36626757-41388D8D-3A90-4FAF-9EE1-5C56FBAD7FFB

Q36626757-4C860E5E-4244-4791-BA28-B0E13B114E3D

Q36626757-6D4DC6E2-C385-4363-8BC3-D01DC2C6CEB0

Q36626757-75604C86-73FE-4252-95F4-E10585C3D0E4

Q36626757-A212C6DE-915D-4B56-9D97-121BC6BF4518

Q36626757-A7E8285B-982C-488E-9FE9-47EE9789C9FD

P2860

Q36626757-00E39C8F-432C-48C2-9126-4F57BE970E3C

Q36626757-0E72E87A-CBC4-4F54-9404-87E40CD5E9A0

Q36626757-17AB259E-8001-465E-8826-9AA2563C2A7F

Q36626757-1977C8B0-DC41-4364-B5A1-4285B6A0745C

Q36626757-1F0266A6-8ED3-49C6-A0DE-B61505198F67

Q36626757-25D4F1AB-4A8F-4F16-9F5B-77B1CDF4D0E5

Q36626757-3DB26E97-3DD8-41BF-AF70-4A6693261C67

Q36626757-44F43698-F2D6-41B0-97FD-D3ABB6792A41

Q36626757-45A73E28-7101-42C2-A097-C26CFC718759

Q36626757-52D45B85-F6E4-408A-910C-094984E66F9D

P304

Q36626757-F7CF95D2-95F7-4FC3-9842-A0800A725B06

P31

Q36626757-81CD44B4-6ED4-4671-9283-F821E1B76577

P356

Q36626757-9493A926-5F56-47C1-8BEE-CEECA2DA5D71

P407

Q36626757-C1AAB525-4040-4993-B9F6-6A2995896FD0

P433

Q36626757-17AADA15-663E-49B3-B267-5DF0BF39A038

P478

Q36626757-A869EFEE-5B98-4BCE-A4A3-E502181E19AD

P577

Q36626757-189DA15F-9D28-4FB8-8970-756AEA22AEA8

P698

Q36626757-EE4D314B-3C60-4CA7-A7CB-CDFB9D92050E

P921

Q36626757-0DB61ECC-C4E0-43DE-AAD6-2F8621EC315B

P932

Q36626757-BF7CE064-5344-40A6-96B0-438F0B609B72

P356

WNL.0B013E318278FE32

P1433

P1476

Lewy pathology is not the firs ...... neurons in Parkinson disease.

@en

P2093

G Webster Ross

http://www.w3.org/2001/XMLSchema#string

Helen Petrovitch

http://www.w3.org/2001/XMLSchema#string

James F Morley

http://www.w3.org/2001/XMLSchema#string

John E Duda

http://www.w3.org/2001/XMLSchema#string

Joseph V Noorigian

http://www.w3.org/2001/XMLSchema#string

Joshua M Milber

http://www.w3.org/2001/XMLSchema#string

Lon White

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

Staging of brain pathology related to sporadic Parkinson's disease

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Stages in the development of Parkinson's disease-related pathology

Ageing and Parkinson's disease: substantia nigra regional selectivity

Evaluation of alpha-synuclein immunohistochemical methods used by invited experts

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study.

Incidental Lewy body disease: clinical comparison to a control cohort.

P304

2307-2314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E318278FE32

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23152586

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3578379

http://www.w3.org/2001/XMLSchema#string